Skip to main content
SpringerLink
Log in

Comparison of Protective Effect of Tri-circulator and Coenzyme Q10 on Myocardial Injury and the Mechanism Study by Zebrafish Model

  • Research
  • Published:
Cardiovascular Toxicology Aims and scope Submit manuscript

Abstract

Tri-Circulator (TC) is a product comprising coenzyme Q10 (CoQ10), Salvia miltiorrhiza, and Panax notoginseng. Individually, each of these constituents has demonstrated protective effects on myocardial injury. The purpose of this study is to evaluate the protective efficacy of TC on heart function and compare the differential effects between CoQ10 and TC. Two myocardial injury models of zebrafish, the hypoxia-reoxygenation model (H/R) and the isoproterenol (ISO, a β-receptor agonist) model, were used in this experiment. The zebrafish subjects were divided into 4 groups: control, H/R, TC, and CoQ10. Heart rate, stroke volume (SV), cardiac output (CO), ejection fraction (EF), fractional area change (FAC), and pericardial height were monitored to assess changes in heart function. The gene expression of atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) was studied as markers of injury/stress. TC significantly suppresses elevated heart rate induced by H/R and prevents the decrease of heart rate induced by ISO. It alleviates the pericardial infusion induced by ISO, whereas CoQ10 does not possess a similar effect. Both TC and CoQ10 significantly inhibit the decline in SV, CO, EF, and FAC induced by H/R and ISO, and suppress the expression of ANP and BNP in cardiomyocytes induced by ISO. It is noteworthy that TC demonstrates a more pronounced effect on EF, FAC, ANP, and BNP gene expression compared to CoQ10. Both TC and CoQ10 have a protective effect on myocardial injury of zebrafish. However, TC exhibits a greater efficacy compared to CoQ10 alone in mitigating myocardial injury.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Data Availability

The data used to support the findings of this study are available from the corresponding author upon request.

Abbreviations

ANP:

Atrial natriuretic peptide

BNP:

Brain natriuretic peptide

CoQ10:

Coenzyme Q10

CO:

Cardiac output

DPF:

Day post fertilization

EF:

Ejection fraction

FAC:

Fractional area change

H/R:

Hypoxia-reoxygenation

ISO:

Isoproterenol

PN:

Panax notoginseng

SM:

Salvia miltiorrhiza

SV:

Stroke-volume

TC:

Tri-circulator

References

  1. Zalewski, J., et al. (2021). Complicating acute myocardial infarction. Current status and unresolved targets for subsequent research. Journal of Clinical Medicine, 10(24), 5904.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Addae-Mensah, K., Revels, J., & Febbo, J. (2022). Pitfalls and pearls in the imaging of cardiac ischemia. Seminars in Ultrasound CT MR, 43(3), 184–193.

    Article  PubMed  Google Scholar 

  3. Lindahl, B., et al. (2017). Medical therapy for secondary prevention and long-term outcome in patients with myocardial infarction with nonobstructive coronary artery disease. Circulation, 135(16), 1481–1489.

    Article  PubMed  Google Scholar 

  4. Salvio, G., et al. (2021). Coenzyme Q10 and male infertility: A systematic review. Antioxidants (Basel, Switzerland), 10(6), 874.

    MathSciNet  CAS  PubMed  Google Scholar 

  5. Aaseth, J., Alexander, J., & Alehagen, U. (2021). Coenzyme Q supplementation—In ageing and disease. Mechanisms of Ageing and Development, 197, 111521.

    Article  CAS  PubMed  Google Scholar 

  6. Hedman, E., & Itkonen, O. (2021). Mitochondrial coenzyme Q10 determination via isotope dilution liquid chromatography-tandem mass spectrometry. Methods in Molecular Biology, 2275, 329–339.

    Article  CAS  PubMed  Google Scholar 

  7. Rabanal-Ruiz, Y., Llanos-González, E., & Alcain, F. (2021). The use of coenzyme Q10 in cardiovascular diseases. Antioxidants (Basel, Switzerland), 10(5), 755.

    CAS  PubMed  Google Scholar 

  8. Chen, W., & Chen, G. (2017). Danshen (Salvia miltiorrhiza Bunge): A prospective healing sage for cardiovascular diseases. Current Pharmaceutical Design, 23(34), 5125–5135.

    CAS  PubMed  Google Scholar 

  9. Yang, F., et al. (2020). Panax notoginseng for cerebral ischemia: A systematic review. The American Journal of Chinese Medicine, 48(6), 1331–1351.

    Article  CAS  PubMed  Google Scholar 

  10. Lin, R., et al. (2021). Salvia miltiorrhiza and the volatile of attenuate chronic myocardial ischemia injury in a pig model: A metabonomic approach for the mechanism study. Oxidative Medicine and Cellular Longevity, 2021, 8840896.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Yu, J., et al. (2015). Danshensu protects isolated heart against ischemia reperfusion injury through activation of Akt/ERK1/2/Nrf2 signaling. International Journal of Clinical and Experimental Medicine, 8(9), 14793–14804.

    CAS  PubMed  PubMed Central  Google Scholar 

  12. Qiao, Z., & Xu, Y. (2016). Salvianolic acid B alleviating myocardium injury in ischemia reperfusion rats. African Journal of Traditional, Complementary, and Alternative Medicines: AJTCAM, 13(4), 157–161.

    Article  MathSciNet  CAS  PubMed  PubMed Central  Google Scholar 

  13. Meng, Y., et al. (2016). Danshensu protects against ischemia/reperfusion injury and inhibits the apoptosis of H9c2 cells by reducing the calcium overload through the p-JNK-NF-κB-TRPC6 pathway. International Journal of Molecular Medicine, 37(1), 258–266.

    Article  CAS  PubMed  Google Scholar 

  14. Li, D., et al. (2016). Salvianolic acid B induced upregulation of miR-30a protects cardiac myocytes from ischemia/reperfusion injury. BMC Complementary and Alternative Medicine, 16, 336.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Hu, H., et al. (2015). Protective effects of tanshinone IIA on myocardial ischemia reperfusion injury by reducing oxidative stress, HMGB1 expression, and inflammatory reaction. Pharmaceutical Biology, 53(12), 1752–1758.

    Article  CAS  PubMed  Google Scholar 

  16. Yuan, X., et al. (2017). Salvianolic acid A protects against myocardial ischemia/reperfusion injury by reducing platelet activation and inflammation. Experimental and Therapeutic Medicine, 14(2), 961–966.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Duan, L., et al. (2017). Panax notoginseng saponins for treating coronary artery disease: A functional and mechanistic overview. Frontiers in Pharmacology, 8, 702.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Wang, D., et al. (2021). Cardioprotection of Panax notoginseng saponins against acute myocardial infarction and heart failure through inducing autophagy. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 136, 111287.

    Article  CAS  Google Scholar 

  19. Zhu, J., et al. (2021). Difenoconazole induces cardiovascular toxicity through oxidative stress-mediated apoptosis in early life stages of zebrafish (Danio rerio). Ecotoxicology and Environmental Safety, 216, 112227.

    Article  CAS  PubMed  Google Scholar 

  20. Narumanchi, S., et al. (2021). Zebrafish heart failure models. Frontiers in Cell and Developmental Biology, 9, 662583.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Zou, X., et al. (2019). A Novel zebrafish larvae hypoxia/reoxygenation model for assessing myocardial ischemia/reperfusion injury. Zebrafish, 16(5), 434–442.

    Article  CAS  PubMed  Google Scholar 

  22. Khdhiri, E., et al. (2021). Cardiopreventive capacity of a novel (E)-N′-(1-(7-methoxy-2-oxo-2H-chromen-3-yl) ethylidene)-4-methylbenzenesulfonohydrazide against isoproterenol-induced myocardial infarction by moderating biochemical, oxidative stress, and histological parameters. Journal of Biochemical and Molecular, 35, e22747.

    CAS  Google Scholar 

  23. Gou, D., et al. (2021). Mog1 knockout causes cardiac hypertrophy and heart failure by downregulating tbx5-cryab-hspb2 signalling in zebrafish. Acta Physiologica (Oxford, England), 231(3), e13567.

    Article  MathSciNet  CAS  PubMed  Google Scholar 

  24. Pasha, R., & Moon, T. W. (2017). Coenzyme Q10 protects against statin-induced myotoxicity in zebrafish larvae (Danio rerio). Environmental Toxicology and Pharmacology, 52, 150–160.

    Article  CAS  PubMed  Google Scholar 

  25. Sawahata, M., et al. (2021). In vivo brain ischemia-reperfusion model induced by hypoxia-reoxygenation using zebrafish larvae. Brain Research Bulletin, 173, 45–52.

    Article  CAS  PubMed  Google Scholar 

  26. Kossack, M., et al. (2017). Induction of cardiac dysfunction in developing and adult zebrafish by chronic isoproterenol stimulation. Journal of Molecular and Cellular Cardiology, 108, 95–105.

    Article  CAS  PubMed  ADS  Google Scholar 

  27. Perumal, E., et al. (2021). Mitigation of arsenic induced developmental cardiotoxicity by ferulic acid in zebrafish. Comparative biochemistry and physiology. Toxicology & Pharmacology: CBP, 244, 109021.

    CAS  Google Scholar 

  28. Derrick, C., et al. (2021). Asymmetric Hapln1a drives regionalised cardiac ECM expansion and promotes heart morphogenesis in zebrafish development. Cardiovascular Research. https://doi.org/10.1093/cvr/cvab004

    Article  PubMed Central  Google Scholar 

  29. Koopman, C., et al. (2021). grimeThe zebrafish mutant uncovers an evolutionarily conserved role for Tmem161b in the control of cardiac rhythm. Proceedings of the National Academy of Sciences of the United States of America. https://doi.org/10.1073/pnas.2018220118

    Article  PubMed  PubMed Central  Google Scholar 

  30. Saini, R. (2011). Coenzyme Q10: The essential nutrient. Journal of Pharmacy & Bioallied Sciences, 3(3), 466–467.

    Article  CAS  Google Scholar 

  31. Zozina, V., et al. (2018). Coenzyme Q10 in cardiovascular and metabolic diseases: Current state of the problem. Current Cardiology Reviews, 14(3), 164–174.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Ren, J., et al. (2019). Salvia miltiorrhiza in treating cardiovascular diseases: A review on its pharmacological and clinical applications. Frontiers in Pharmacology, 10, 753.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Yang, X., et al. (2014). Protective effects of panax notoginseng saponins on cardiovascular diseases: A comprehensive overview of experimental studies. Evidence-Based Complementary and Alternative Medicine: ECAM, 2014, 204840.

    Article  PubMed  Google Scholar 

  34. Zhou, X., et al. (2016). Synergistic effects of Danshen (Salvia miltiorrhiza Radix et Rhizoma) and Sanqi (Notoginseng Radix et Rhizoma) combination in inhibiting inflammation mediators in RAW264.7 Cells. BioMed Research International, 2016, 5758195.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Han, J., et al., Traditional Chinese drug comprising Danshen extracts and Sanqi extracts and use thereof. US.

  36. Ren-an, Q., et al. (2014). Study of the protective mechanisms of compound Danshen Tablet (Fufang Danshen Pian) against myocardial ischemia/reperfusion injury via the Akt-eNOS signaling pathway in rats. Journal of Ethnopharmacology, 156, 190–198.

    Article  PubMed  Google Scholar 

  37. Chengode, S. (2016). Left ventricular global systolic function assessment by echocardiography. Annals of Cardiac Anaesthesia, 19, S26–S34.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Potter, L., et al. (2009). Natriuretic peptides: Their structures, receptors, physiologic functions and therapeutic applications. Handbook of Experimental Pharmacology, 191, 341–366.

    Article  CAS  Google Scholar 

  39. Sun, S., et al. (2018). Dendropanax morbifera prevents cardiomyocyte hypertrophy by inhibiting the Sp1/GATA4 pathway. American Journal of Chinese Medicine, 46(5), 1021–1044.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work is supported by TCM Health Education & Research Center, USA.

Author information

Authors and Affiliations

  1. State Key Laboratory of Bioactive Molecules and Druggability Assessment, Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Chinese Ministry of Education (MOE), College of Pharmacy, Jinan University, 601 Huangpu Avenue West, Guangzhou, 510632, China

    Yuan Xiao, Ranjing Wang, Shang Kong, Tingting Zhao, Yongli Situ & Hong Nie

Authors
  1. Yuan Xiao
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ranjing Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shang Kong
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Tingting Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yongli Situ
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hong Nie
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

YX, RW, and SK contributed toward conceptualization, writing–review & editing, formal analysis, writing–original draft, and methodology. TZ contributed toward formal analysis, and writing–original draft. YX contributed toward methodology and software. YS contributed toward validation. HN contributed toward conceptualization, writing–review & editing, funding acquisition, supervision, methodology, and project administration.

Corresponding author

Correspondence to Hong Nie.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Handling Editor: Daniel Conklin.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xiao, Y., Wang, R., Kong, S. et al. Comparison of Protective Effect of Tri-circulator and Coenzyme Q10 on Myocardial Injury and the Mechanism Study by Zebrafish Model. Cardiovasc Toxicol 24, 258–265 (2024). https://doi.org/10.1007/s12012-024-09828-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12012-024-09828-7

Keywords

Search

Navigation